Canada
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 161.37 M
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
2 |
USD 62.13 M
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
3 |
USD 38.02 M
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
4 |
USD 530.41 K
|
Dec. 31, 2023 | USD 0.15 | -5.56% |
|
Canada |
|
5 |
USD 0.00
|
Sept. 30, 2024 | USD 1.91 | 1.06% |
|
Canada |
|
6 |
USD -3.69 K
|
March 31, 2024 | USD 0.85 | -3.04% |
|
Canada |
|
7 |
USD -66.50 K
|
June 30, 2024 | NA |
|
Canada |
||
8 |
USD -141.96 K
|
Dec. 31, 2023 | USD 0.89 | -2.92% |
|
Canada |
|
9 |
USD -187.38 K
|
Dec. 31, 2023 | USD 1.45 | 3.65% |
|
Canada |
|
10 |
USD -304.06 K
|
Dec. 31, 2023 | USD 0.73 | 3.09% |
|
Canada |
The Vaccines company in Canada with the highest Gross Profit is Aurinia Pharmaceuticals Inc. (NasdaqGM: AUPH) at USD 161.37 M.
The Vaccines company in Canada with the lowest Gross Profit is Oncolytics Biotech Inc. (Toronto Stock Exchange: ONC.TO) at USD -304.06 K.
The top 10 Vaccines companies in Canada by Gross Profit are Aurinia Pharmaceuticals Inc., Theratechnologies Inc., AbCellera Biologics Inc., Ondine Biomedical Inc., Edesa Biotech, Inc., Medicenna Therapeutics Corp., Defence Therapeutics Inc., XORTX Therapeutics Inc., Cardiol Therapeutics Inc. and Oncolytics Biotech Inc..
The bottom 10 Vaccines companies in Canada by Gross Profit are Oncolytics Biotech Inc., Cardiol Therapeutics Inc., XORTX Therapeutics Inc., Defence Therapeutics Inc., Medicenna Therapeutics Corp., Edesa Biotech, Inc., Ondine Biomedical Inc., AbCellera Biologics Inc., Theratechnologies Inc. and Aurinia Pharmaceuticals Inc..